These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016. Barbieri JS; Choi JK; Mitra N; Margolis DJ J Drugs Dermatol; 2018 Jun; 17(6):632-638. PubMed ID: 29879250 [TBL] [Abstract][Full Text] [Related]
26. Duration of oral tetracycline-class antibiotic therapy and use of topical retinoids for the treatment of acne among general practitioners (GP): A retrospective cohort study. Barbieri JS; Hoffstad O; Margolis DJ J Am Acad Dermatol; 2016 Dec; 75(6):1142-1150.e1. PubMed ID: 27502311 [TBL] [Abstract][Full Text] [Related]
27. Topical clindamycin versus oral tetracycline and placebo in acne vulgaris. Braathen LR Scand J Infect Dis Suppl; 1984; 43():71-5. PubMed ID: 6242073 [TBL] [Abstract][Full Text] [Related]
29. Sarecycline hydrochloride for the treatment of acne vulgaris. Kaul G; Saxena D; Dasgupta A; Chopra S Drugs Today (Barc); 2019 Oct; 55(10):615-625. PubMed ID: 31720559 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study. Leyden JJ; Sniukiene V; Berk DR; Kaoukhov A J Drugs Dermatol; 2018 Mar; 17(3):333-338. PubMed ID: 29537451 [TBL] [Abstract][Full Text] [Related]
32. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne. Toossi P; Farshchian M; Malekzad F; Mohtasham N; Kimyai-Asadi A J Drugs Dermatol; 2008 Dec; 7(12):1149-52. PubMed ID: 19137768 [TBL] [Abstract][Full Text] [Related]
33. Non-antibiotic properties of tetracyclines and their clinical application in dermatology. Perret LJ; Tait CP Australas J Dermatol; 2014 May; 55(2):111-8. PubMed ID: 23808657 [TBL] [Abstract][Full Text] [Related]
34. High-dose tetracycline therapy in severe acne. Baer RL; Leshaw SM; Shalita AR Arch Dermatol; 1976 Apr; 112(4):479-81. PubMed ID: 131512 [TBL] [Abstract][Full Text] [Related]
35. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Ozolins M; Eady EA; Avery AJ; Cunliffe WJ; Po AL; O'Neill C; Simpson NB; Walters CE; Carnegie E; Lewis JB; Dada J; Haynes M; Williams K; Williams HC Lancet; 2004 Dec 18-31; 364(9452):2188-95. PubMed ID: 15610805 [TBL] [Abstract][Full Text] [Related]
36. Minocycline versus doxycycline in the treatment of acne vulgaris. A double-blind study. Smit F Dermatologica; 1978; 157(3):186-90. PubMed ID: 150346 [No Abstract] [Full Text] [Related]
37. Minocycline in acne vulgaris: benefits and risks. Ochsendorf F Am J Clin Dermatol; 2010; 11(5):327-41. PubMed ID: 20642295 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of minocycline compared with tetracycline in treatment of acne vulgaris. Hubbell CG; Hobbs ER; Rist T; White JW Arch Dermatol; 1982 Dec; 118(12):989-92. PubMed ID: 6216858 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic focus. Minocycline in the treatment of acne. Freeman K Br J Clin Pract; 1989 Mar; 43(3):112-5. PubMed ID: 2532925 [TBL] [Abstract][Full Text] [Related]